| Author (Corporate) | European Commission |
|---|---|
| Series Title | COM |
| Series Details | (2012) 548 final (27.9.12) |
| Publication Date | 27/09/2012 |
| Content Type | Policy-making |
|
Many chemicals are used in a wide variety of important industrial processes (e.g. in the synthesis of plastics, pharmaceuticals, cosmetics, perfumes, detergents and aromas) and they are traded for these licit uses on regional and global markets. Some of these chemicals can, however, be misused for the illicit manufacture of narcotic drugs and psychotropic substances. The chemicals produced for a licit purpose which can be misused in the illegal drug production are called drug precursors. Drug precursors are rarely produced by the criminals that intend to use them in the illicit manufacture of drugs, as their production often requires important industrial infrastructure. Therefore, criminals try to divert these substances from the licit trade. The trade in drug precursors is not in itself prohibited because of their important legitimate uses. However, in order to prevent their diversion to illicit drug production, a specific regulatory framework has been set up on international level through Article 12 of the United Nations Convention against the Illicit Traffic in Narcotic Drugs and Psychotropic Substances. The European Union is a Party to the Convention and has implemented its obligations through Regulation (EC) No 273/2004 governing the monitoring of the intra-EU trade in drug precursors and Regulation (EC) No 111/2005 governing the external trade. |
|
| Source Link | Link to Main Source http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2012:0548:FIN:EN:PDF |
| Related Links |
|
| Subject Categories | Health, Justice and Home Affairs |
| Countries / Regions | Europe |
